crmd stock price: CorMedix (CRMD) stock guide

CRMD (CorMedix, Inc.) — Stock price

Overview: This guide explains the crmd stock price, how quotes work, where CRMD trades, what drives its market moves, and how investors and traders can monitor the ticker with reliable data and Bitget tools. The article is aimed at beginners and intermediate readers who want factual, neutral, and actionable guidance for following CRMD.

Company overview

CorMedix, Inc. (ticker: CRMD) is a clinical-stage pharmaceutical and medical-device company focused on therapies to prevent and treat infections associated with medical procedures and devices. Founded in the 1990s and headquartered in the United States, CorMedix develops products that target unmet needs in hospital-acquired infections and complications tied to catheter- or device-related care.

The company’s development pipeline and any marketed products form the core of investor interest. Key product candidates or commercial products historically emphasized by CorMedix include antiseptic or antimicrobial device-related treatments intended for perioperative or critical-care settings. Clinical progress, regulatory decisions, and initial commercial traction for any approved products have outsized influence on the crmd stock price because the company’s financial profile typically depends heavily on a small number of assets and milestone-driven value creation.

Ticker and listing information

• Ticker symbol: CRMD
• Company: CorMedix, Inc.
• Listing venue: NASDAQ (U.S. equities exchange)
• Trading currency: U.S. dollars (USD)
• Typical regular trading hours (U.S. Eastern Time): 09:30–16:00
• Extended hours: pre-market and after-hours sessions may display quotes and trades outside regular hours
• Market sector / industry: Healthcare — Pharmaceuticals / Medical Devices / Biotech (company classifications may vary across data providers)

Note: The crmd stock price that retail platforms display can be real-time (for subscribers) or delayed (commonly 15–20 minutes) depending on the data source and user account privileges.

Current market data and quote

A stock quote for CRMD typically shows the following fields: last trade price, absolute change (price difference from previous close), percent change, bid price, ask price, bid size/ask size, intraday high and low, volume (trades/shares during the trading day), average daily volume, market capitalization, shares outstanding, and high/low over 52 weeks.

• What a quote means: The last price is the most recent executed trade. Bid and ask show the highest buyer and lowest seller prices currently in the market; wide spreads can indicate low liquidity. Volume indicates intraday trading activity and helps assess how actively the stock moves.
• Real-time vs. delayed data: Many public websites and apps provide delayed quotes without a subscription. Professional feeds (and many brokerage platforms) can provide real-time streaming quotes for NASDAQ-listed names.
• Common live quote sources: official NASDAQ feeds, Google Finance, MarketWatch, Yahoo Finance quote pages, brokerage apps. Bitget also offers market data and trading interfaces where eligible U.S. equity trading features are supported; track CRMD on Bitget for consolidated trade execution and alerts.

As of 2026-01-29, according to NASDAQ’s market page and other data providers, quotes for CRMD are published in U.S. dollars and include intraday and after-hours reporting. When consulting any quote, check the timestamp and whether the feed is real-time or delayed.

Historical price performance

Intraday and short-term trends

Intraday price action for CRMD can be volatile compared with large-cap, blue-chip stocks. Short-term moves in the crmd stock price are often triggered by company press releases (clinical data, regulatory milestones), earnings or financing announcements, analyst notes, or sector-wide news that affects small-cap healthcare names.

Traders watching intraday behavior typically look at: current-day high/low ranges, 5–15 minute candlestick charts, intraday volume spikes, and order book changes (bid/ask spread behavior). Momentum indicators like short-term moving averages (e.g., 9-period and 20-period on intraday charts) help spot near-term momentum shifts.

Medium- and long-term performance

Medium- and long-term trends for the crmd stock price reflect cumulative outcomes: clinical trial results, regulatory approvals or denials, successful commercialization, periodic earnings/financial disclosures, capital raises (which can dilute existing shareholders), and sustained revenue trajectories if a product reaches market.

Key long-term metrics investors often check include:

• 52-week high and low: gives a sense of recent range and volatility
• Multi-year charts: show trend direction (uptrend, downtrend, or range-bound)
• Major dated events: clinical readouts, FDA communications, or large financing rounds usually align with noticeable moves in price

As of 2026-01-29, several market-data services and financial news outlets record historical highs and lows and plot CRMD’s long-term chart for investors to evaluate trend context. Investors should cross-check the 52-week range across multiple quote providers for consistency.

Financial results and fundamentals

Fundamental evaluation for a small pharmaceutical/medical-device company like CorMedix centers on revenue, operating income (or losses), net cash or debt positions, research and development expenses, and the near-term funding runway.

Typical fundamental items that materially affect valuation and therefore the crmd stock price:

• Revenue and product sales (if any commercialized products exist)
• Net loss or profit and earnings-per-share (EPS) — many early-stage healthcare companies report losses while funding development
• Cash and short-term investments: determine how long the company can operate without additional capital
• Outstanding shares and potential dilution from secondary offerings or convertible securities
• Balance-sheet items such as debt maturities and lease obligations

As of 2026-01-29, financial statements and quarterly/annual reports filed with regulatory authorities (for example, the U.S. SEC) provide the official numbers investors use to update models and valuations. When reviewing the crmd stock price in relation to fundamentals, always consult the company’s latest 10-Q (quarterly report) or 10-K (annual report) for audited or management-discussed figures.

Drivers of stock price

Movements in the crmd stock price are driven by a combination of company-specific factors and broader market forces. Principal driver categories include:

Product sales and commercial performance

If CorMedix has revenue-generating products, quarterly sales growth or contraction will directly impact investor sentiment. Key aspects include:

• Sales trends by product and geography
• Gross margins on sales and any reimbursement dynamics (e.g., hospital purchasing, insurance coverage)
• Real-world adoption rates and purchasing agreements with healthcare systems

Improving sales and evidence of commercialization scale tend to support higher valuations, while weak uptake or disputed efficacy can pressure the crmd stock price.

Clinical and regulatory milestones

Clinical trial results, regulatory filings, and approvals are among the most significant drivers for biotech and medical-device stocks. For CorMedix, typical catalysts include:

• Positive/negative primary endpoint results in pivotal trials
• FDA or other regulatory agency clearance, approval, or issuance of complete response letters
• Changes in trial design, enrollment success, or safety signals

Regulatory success or setbacks often cause sharp short-term moves in the crmd stock price as investors reprice future revenue probabilities.

Partnerships, distribution, and contracts

Licensing agreements, distribution partnerships, sales contracts with major health systems, or OEM collaborations can materially shift the company’s revenue outlook. Announcements of such commercial agreements may reduce execution risk and can positively affect the crmd stock price.

Large supply agreements or strategic collaborations that provide milestone payments or revenue guarantees tend to be viewed favorably by the market.

News, announcements, and recent catalysts

News items commonly producing noticeable reactions in the crmd stock price include:

• Company press releases about trial results, regulatory feedback, or commercialization progress
• Quarterly earnings releases and accompanying management commentary
• Announced capital raises (which can dilute and pressure the stock)
• Analyst coverage changes and published research notes
• Industry or competitor developments that influence relative competitiveness or market size

As of 2026-01-29, financial news sites and the company’s investor relations updates are primary sources for recent corporate announcements that have moved the stock. Investors typically follow both official company releases and consolidated market reporting for context.

Analyst coverage and price targets

Analyst reports and published price targets can affect retail and institutional interest in the crmd stock price. Coverage for smaller healthcare companies may be limited compared with large-cap names; when a reputable analyst initiates or revises coverage, that action can draw attention.

• Rating changes (e.g., from Neutral to Buy) or price-target adjustments are often cited in the media and may correlate with intraday price changes.
• Consensus price targets (aggregated across multiple analysts) provide a central tendency, but for thinly covered names this metric can be unstable.

Sources that publish analyst commentary include broker research platforms and financial-news aggregators. Investors should note the publication date and analyst assumptions when reviewing price targets.

Technical analysis and market sentiment

Technical indicators commonly applied to CRMD include moving averages (50-day, 200-day), relative strength index (RSI), MACD, and volume-based indicators. For small-cap healthcare stocks, traders also monitor:

• Support and resistance levels established by prior intraday or multi-week lows/highs
• Gap fills after overnight news-driven moves
• Volume spikes that confirm momentum

Market sentiment also emerges from social platforms and trader chat rooms. Sources like Stocktwits aggregate user messages and sentiment tags; such social signals sometimes precede short-term volatility for thinly traded stocks. As of 2026-01-29, social sentiment metrics remain supplemental and should be interpreted in the context of verified news and on-chain market data where applicable.

Short interest is an additional metric: elevated short interest can increase the potential for short squeezes if positive news forces short-covering. Conversely, persistent high short interest often signals skepticism about near-term fundamentals.

Trading information and liquidity

Liquidity considerations for the crmd stock price include average daily volume, bid-ask spread width, and the size of stepped orders in the order book. Lower liquidity can lead to slippage—where your executed price differs from the expected price—especially with larger order sizes.

Typical trading considerations:

• Average daily volume: helps estimate how easy it is to enter or exit sizable positions without moving the market
• Bid-ask spread: wider spreads increase implicit trading costs
• After-hours and pre-market trading: these sessions typically have lower liquidity and higher spreads, making execution riskier

For retail investors and traders, using limit orders and monitoring liquidity conditions can reduce unintended price impact when trading CRMD. Bitget’s platform provides execution tools, alerts, and order types designed to manage slippage and liquidity risk for users who track equities in addition to crypto assets.

Risks and investment considerations

Risks that can influence the crmd stock price include:

• Company-specific clinical or regulatory setbacks: negative trial results or regulatory refusals often produce steep declines
• Product concentration: reliance on a small number of candidates or a single marketed product increases exposure
• Financing and dilution: early-stage healthcare companies frequently raise capital; new share issuances can dilute existing holders and pressure the share price
• Competition and market adoption: competing products or therapies may reduce the commercial potential of CorMedix’s offerings
• General biotech volatility: the healthcare and biotech sectors are prone to rapid sentiment shifts tied to newsflow

Investors should perform due diligence: review the company’s latest SEC filings, understand the development timeline, and factor in potential dilution when assessing how the crmd stock price may behave under different outcomes.

Note: This article presents factual information and analysis methods. It is not investment advice.

Historical corporate actions affecting price

Corporate actions that historically influence share counts and market perception include:

• Secondary offerings and registered direct offerings: increase shares outstanding and can depress the crmd stock price upon announcement
• Convertible debt issuances or conversions: convertibles can dilute equity if converted
• Insider buying or selling: substantial insider transactions are scrutinized for signals about management’s view of valuation
• Stock splits or reverse splits: splits adjust the share count and per-share price, often for listing compliance or marketability reasons

As with any ticker, checking the company’s investor relations and SEC filings provides the official record of these corporate actions and the dates they took effect.

How to track CRMD stock price

Reliable ways to follow the crmd stock price include:

• Official exchange pages and consolidated market-data providers for time-stamped quotes
• Financial news sites that aggregate market data and provide historical charts
• Brokerage platforms that stream real-time quotes (verify whether data is delayed or real-time for your account type)
• Alerts and watchlists in trading platforms: set price alerts for last trade, bid/ask, or percent-change thresholds

As of 2026-01-29, the major market-data pages and brokerages publish quotes and historical charts for CRMD. Bitget users can add CRMD to watchlists, receive push or email alerts for significant price or volume moves, and use the Bitget Wallet to manage cross-asset holdings. When relying on any single source, confirm timestamps and data latency, and cross-check with the company’s official filings when making decisions that depend on precise fundamentals.

See also

• NASDAQ Biotechnology Index (for sector context)
• Comparable companies in medical devices and biopharma (companies with similar market-focus or pipeline-stage)
• Investor resources: SEC EDGAR filings, company investor relations releases, clinicaltrials.gov entries for trial details

References

• NASDAQ market data and company page for CRMD — list of trading quotes and historical data. (As of 2026-01-29, according to NASDAQ.)
• Google Finance CRMD quote and charting tools. (As of 2026-01-29, according to Google Finance reporting.)
• MarketWatch CRMD coverage including news and historical performance charts. (As of 2026-01-29, according to MarketWatch.)
• Yahoo Finance symbol lookup and consolidated quote page for CRMD. (As of 2026-01-29, according to Yahoo Finance.)
• Robinhood’s publicly displayed CRMD quote page. (As of 2026-01-29, according to Robinhood.)
• Zacks investment research coverage on CorMedix, including fundamental summaries. (As of 2026-01-29, according to Zacks.)
• Stocktwits stream for CRMD trader sentiment and message activity. (As of 2026-01-29, according to Stocktwits.)
• SoFi and CNN Markets summary pages that aggregate financial metrics and news for CRMD. (As of 2026-01-29, according to SoFi and CNN Markets.)

Note: Each reference above provides time-stamped market-data or news pages. For official financial statements and corporate filings, consult the company’s investor relations and the SEC filings database.

External links

• CorMedix investor relations page and SEC filings (official filings and company disclosures).
• Live-quote pages and consolidated market-data providers where CRMD is listed.

Tracking and next steps: To monitor the crmd stock price in real time and receive alerts on price, volume, or news, add CRMD to your Bitget watchlist and ensure market-data permissions are configured for real-time updates. For custody and cross-asset portfolio management, consider Bitget Wallet for secure asset oversight.

Disclosure: This article is informational and educational in nature. It contains no investment advice or recommendations. Readers should verify live data from official sources and consult licensed financial professionals for personalized advice.